NDC properties for "Abrilada 40 MG per 0.8 ML Prefilled Syringe" (RxCUI 2668078)
About this data
The tables show NDC propoerties for Abrilada 40 MG per 0.8 ML Prefilled Syringe with the RxCUI 2668078
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Abrilada 40 MG per 0.8 ML Prefilled Syringe (RxCUI 2668078)
| BLA | BLA761118 |
|---|---|
| MMSL_CODE | BD38873 |
| RxCUI | 2668078 |
| SPL_SET_ID | 5ef1c7cf-466f-495e-8d13-82e2ddfa7a4f |
| SPL_SET_ID | 81a33cfa-262f-4432-a05d-7dd260928437 |
| Prescribable Synonym | Abrilada 40 MG in 0.8 ML Prefilled Syringe |
| RXNAV_STR | Abrilada 40 MG per 0.8 ML Prefilled Syringe |
| RxNorm Name | 0.8 ML adalimumab-afzb 50 MG/ML Prefilled Syringe [Abrilada] |
| RxNorm Synonym | Abrilada 40 MG per 0.8 ML Prefilled Syringe |
| RxNorm Synonym | Abrilada 50 MG/ML per 0.8 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2668078) |
NDC Properties
NDC Item 00025031701
| NDC 9 | 0025-0317 |
|---|---|
| NDC 10 | 0025-0317-01 |
| NDC Item | 00025031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0025-0317 |
NDC Item 00025032801
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-01 |
| NDC Item | 00025032801 |
| Packaging | 1 KIT in 1 CARTON (0025-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00025032802
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-02 |
| NDC Item | 00025032802 |
| Packaging | 2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00069031701
| NDC 9 | 0069-0317 |
|---|---|
| NDC 10 | 0069-0317-01 |
| NDC Item | 00069031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0069-0317 |
NDC Item 00069032801
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-01 |
| NDC Item | 00069032801 |
| Packaging | 1 KIT in 1 CARTON (0069-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00069032802
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-02 |
| NDC Item | 00069032802 |
| Packaging | 2 KIT in 1 CARTON (0069-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00025031701
| NDC 9 | 0025-0317 |
|---|---|
| NDC 10 | 0025-0317-01 |
| NDC Item | 00025031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0025-0317 |
NDC Item 00025032801
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-01 |
| NDC Item | 00025032801 |
| Packaging | 1 KIT in 1 CARTON (0025-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00025032802
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-02 |
| NDC Item | 00025032802 |
| Packaging | 2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00069031701
| NDC 9 | 0069-0317 |
|---|---|
| NDC 10 | 0069-0317-01 |
| NDC Item | 00069031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0069-0317 |
NDC Item 00069032801
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-01 |
| NDC Item | 00069032801 |
| Packaging | 1 KIT in 1 CARTON (0069-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00069032802
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-02 |
| NDC Item | 00069032802 |
| Packaging | 2 KIT in 1 CARTON (0069-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00025031701
| NDC 9 | 0025-0317 |
|---|---|
| NDC 10 | 0025-0317-01 |
| NDC Item | 00025031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0025-0317 |
NDC Item 00025032801
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-01 |
| NDC Item | 00025032801 |
| Packaging | 1 KIT in 1 CARTON (0025-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00025032802
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-02 |
| NDC Item | 00025032802 |
| Packaging | 2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00069031701
| NDC 9 | 0069-0317 |
|---|---|
| NDC 10 | 0069-0317-01 |
| NDC Item | 00069031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0069-0317 |
NDC Item 00069032801
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-01 |
| NDC Item | 00069032801 |
| Packaging | 1 KIT in 1 CARTON (0069-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00069032802
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-02 |
| NDC Item | 00069032802 |
| Packaging | 2 KIT in 1 CARTON (0069-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00025031701
| NDC 9 | 0025-0317 |
|---|---|
| NDC 10 | 0025-0317-01 |
| NDC Item | 00025031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0025-0317 |
NDC Item 00025032801
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-01 |
| NDC Item | 00025032801 |
| Packaging | 1 KIT in 1 CARTON (0025-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00025032802
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-02 |
| NDC Item | 00025032802 |
| Packaging | 2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00069031701
| NDC 9 | 0069-0317 |
|---|---|
| NDC 10 | 0069-0317-01 |
| NDC Item | 00069031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0069-0317 |
NDC Item 00069032801
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-01 |
| NDC Item | 00069032801 |
| Packaging | 1 KIT in 1 CARTON (0069-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00069032802
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-02 |
| NDC Item | 00069032802 |
| Packaging | 2 KIT in 1 CARTON (0069-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00025031701
| NDC 9 | 0025-0317 |
|---|---|
| NDC 10 | 0025-0317-01 |
| NDC Item | 00025031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0025-0317 |
NDC Item 00025032801
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-01 |
| NDC Item | 00025032801 |
| Packaging | 1 KIT in 1 CARTON (0025-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00025032802
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-02 |
| NDC Item | 00025032802 |
| Packaging | 2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00069031701
| NDC 9 | 0069-0317 |
|---|---|
| NDC 10 | 0069-0317-01 |
| NDC Item | 00069031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0069-0317 |
NDC Item 00069032801
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-01 |
| NDC Item | 00069032801 |
| Packaging | 1 KIT in 1 CARTON (0069-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00069032802
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-02 |
| NDC Item | 00069032802 |
| Packaging | 2 KIT in 1 CARTON (0069-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00025031701
| NDC 9 | 0025-0317 |
|---|---|
| NDC 10 | 0025-0317-01 |
| NDC Item | 00025031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0025-0317 |
NDC Item 00025032801
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-01 |
| NDC Item | 00025032801 |
| Packaging | 1 KIT in 1 CARTON (0025-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00025032802
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-02 |
| NDC Item | 00025032802 |
| Packaging | 2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0328 |
NDC Item 00069031701
| NDC 9 | 0069-0317 |
|---|---|
| NDC 10 | 0069-0317-01 |
| NDC Item | 00069031701 |
| Packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | active |
| Related queries | Properties for NDC 9 0069-0317 |
NDC Item 00069032801
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-01 |
| NDC Item | 00069032801 |
| Packaging | 1 KIT in 1 CARTON (0069-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |
NDC Item 00069032802
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-02 |
| NDC Item | 00069032802 |
| Packaging | 2 KIT in 1 CARTON (0069-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0328 |